CARCINOIDS - THE PROGNOSTIC EFFECT OF PRIMARY SITE HISTOLOGIC TYPE VARIATIONS

被引:11
作者
JOHNSON, LA
LAVIN, PT
MOERTEL, CG
WEILAND, LH
DAYAL, YY
DOOS, WG
GELLER, SA
COOPER, HS
MASSE, SR
ENGSTROM, PF
机构
[1] BROWN UNIV,ROGER WILLIAMS GEN HOSP,DEPT PATHOL & LAB MED,MED PROGRAM,PROVIDENCE,RI 02908
[2] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV BIOSTAT,BOSTON,MA 02115
[3] MAYO CLIN & MAYO FDN,COMPREHENS CANC CLIN,ROCHESTER,MN 55905
[4] MAYO CLIN & MAYO FDN,DEPT PATHOL,ROCHESTER,MN 55905
[5] TUFTS UNIV,NEW ENGLAND MED CTR HOSP,SCH MED,DEPT PATHOL,BOSTON,MA 02111
[6] BOSTON UNIV,VET ADM HOSP,SCH MED,DEPT PATHOL,BOSTON,MA 02215
[7] CUNY MT SINAI SCH MED,DEPT PATHOL,NEW YORK,NY 10029
[8] THOMAS JEFFERSON UNIV HOSP,DEPT PATHOL,PHILADELPHIA,PA 19107
[9] CHU SHERBROOKE,DEPT PATHOL,SHERBROOKE J1H 5N4,QUEBEC,CANADA
[10] AMER ONCOL HOSP,DEPT MED ONCOL,PHILADELPHIA,PA 19111
关键词
D O I
10.1002/jso.2930330204
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:81 / 83
页数:3
相关论文
共 7 条
[1]  
COX DR, 1972, J R STAT SOC B, V34, P187
[2]  
Cox DR., 1990, BIOMETRICS, V46, P550, DOI DOI 10.2307/2531476
[3]  
JOHNSON LA, 1983, CANCER-AM CANCER SOC, V51, P882, DOI 10.1002/1097-0142(19830301)51:5<882::AID-CNCR2820510522>3.0.CO
[4]  
2-8
[5]  
Moertel C G, 1979, Cancer Clin Trials, V2, P327
[6]  
SOGA J, 1971, CANCER-AM CANCER SOC, V28, P990, DOI 10.1002/1097-0142(1971)28:4<990::AID-CNCR2820280424>3.0.CO
[7]  
2-K